Literature DB >> 26615113

Responsive Direct Brain Stimulation for Epilepsy.

Martha J Morrell1, Casey Halpern2.   

Abstract

Closed-loop, responsive focal brain stimulation provides a new treatment option for patients with refractory partial onset seizures who are not good candidates for potentially curative epilepsy surgery. The first responsive brain neurostimulator (RNS® System, NeuroPace), provides stimulation directly to the seizure focus when abnormal electrocorticographic is detected. Seizure reductions of 44% at one year increase to 60 to 66% at years 3 to 6 of treatment. There is no negative impact on cognition and mood. Risks are similar to other implanted medical devices and therapeutic stimulation is not perceived.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Closed-loop; Electrocorticogram; Epilepsy; Intracranial; Intractable; Neurostimulator; Responsive; Stimulation

Mesh:

Year:  2016        PMID: 26615113     DOI: 10.1016/j.nec.2015.08.012

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  17 in total

Review 1.  Deep Brain Stimulation for Epilepsy: Biomarkers for Optimization.

Authors:  Katrina L Dell; Mark J Cook; Matias I Maturana
Journal:  Curr Treat Options Neurol       Date:  2019-09-26       Impact factor: 3.598

2.  Cloud computing for seizure detection in implanted neural devices.

Authors:  Steven Baldassano; Xuelong Zhao; Benjamin Brinkmann; Vaclav Kremen; John Bernabei; Mark Cook; Timothy Denison; Gregory Worrell; Brian Litt
Journal:  J Neural Eng       Date:  2018-12-18       Impact factor: 5.379

Review 3.  Closed-loop neuromodulation systems: next-generation treatments for psychiatric illness.

Authors:  Meng-Chen Lo; Alik S Widge
Journal:  Int Rev Psychiatry       Date:  2017-02-10

Review 4.  Deep brain stimulation for the treatment of disorders of consciousness and cognition in traumatic brain injury patients: a review.

Authors:  Bornali Kundu; Andrea A Brock; Dario J Englot; Christopher R Butson; John D Rolston
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

5.  Secondary generalization of focal-onset seizures: examining the relationship between seizure propagation and epilepsy surgery outcome.

Authors:  Samuel B Tomlinson; Arun Venkataraman
Journal:  J Neurophysiol       Date:  2016-10-05       Impact factor: 2.714

6.  Association of Closed-Loop Brain Stimulation Neurophysiological Features With Seizure Control Among Patients With Focal Epilepsy.

Authors:  Vasileios Kokkinos; Nathaniel D Sisterson; Thomas A Wozny; R Mark Richardson
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

7.  Chronic ambulatory electrocorticography from human speech cortex.

Authors:  Vikram R Rao; Matthew K Leonard; Jonathan K Kleen; Ben A Lucas; Emily A Mirro; Edward F Chang
Journal:  Neuroimage       Date:  2017-04-07       Impact factor: 6.556

8.  Restoring Conscious Arousal During Focal Limbic Seizures with Deep Brain Stimulation.

Authors:  Adam J Kundishora; Abhijeet Gummadavelli; Chanthia Ma; Mengran Liu; Cian McCafferty; Nicholas D Schiff; Jon T Willie; Robert E Gross; Jason Gerrard; Hal Blumenfeld
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

9.  Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS?

Authors:  Joseph J Taylor; John H Krystal; Deepak C D'Souza; Jason Lee Gerrard; Philip R Corlett
Journal:  Schizophr Res       Date:  2017-09-29       Impact factor: 4.939

10.  Brain-Responsive Neurostimulation for Loss of Control Eating: Early Feasibility Study.

Authors:  Hemmings Wu; Sarah Adler; Dan E Azagury; Cara Bohon; Debra L Safer; Daniel A N Barbosa; Mahendra T Bhati; Nolan R Williams; Laura B Dunn; Peter A Tass; Brian D Knutson; Maya Yutsis; Ayesha Fraser; Tricia Cunningham; Kara Richardson; Tara L Skarpaas; Thomas K Tcheng; Martha J Morrell; Laura Weiss Roberts; Robert C Malenka; James D Lock; Casey H Halpern
Journal:  Neurosurgery       Date:  2020-11-16       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.